±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 285  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

Discovery8231

[½»Á÷] ¿ÉÒÔÉêÇë"ÐÂÒ©Ñз¢Á÷³ÌÑÐÌÖ»á"ѧÉúÃâ·Ñ²Î»áÃû¶î²¢Óлú»áÓ®ipod touch

¿´µ½Óлú»áÉêÇëÕâ¸ö»áÒéµÄѧÉúÃâ·ÑÃû¶î£¬ºÇºÇ¡£»¹Óлú»á³é½±ipod touch¡£×ªÀ´¸ú´ó¼Ò·ÖÏíһϡ£

´Ë´Î»áÒéÕë¶ÔѧÉúÓÐÊý¸öÃâ·ÑÃû¶î¡£ÔÚ10ÔÂ15ºÅ֮ǰÌá½»»ØÖ´µÄѧÉú£¬Èç¹ûûÓÐÉêÇëµ½Ãâ·ÑÃû¶îÕߣ¬ÈÔ°´400Ôª/È˼ÆËã¡£¾­ÉóÆÀ»ñµÃÃâ·ÑÃû¶îµÄѧÉú¿ÉÔÚ10Ôµ׵õ½Í¨Öª¡£

µÚÒ»½ìÐÂÒ©Ñз¢Á÷³Ì¼°ÆäÐÅÏ¢»¯ÑÐÌÖ»á
µÚ¶þÂÖ֪ͨ

×¢£ºÈç¹ûÒÔÏÂÄÚÈÝÎÞ·¨Õý³£ÏÔʾ£¬Çëµã»÷http://www.drugdiscovery-china.cn/
»áÒé¼ò½é
×ÔÖйú¼ÓÈëWTOÒÔÀ´£¬Ãæ¶Ô¹ú¼ÊÒ½Ò©½ç¼¤ÁÒµÄÊг¡¾ºÕùÓë¿ÆÑоºÕù£¬ÐÂÒ©Ñз¢ÊµÁ¦µÄ¿ìËÙÌáÉý¶ÔÓÚÎÒ¹úÉúÎïÖÆÒ©ÆóÒµÀ´Ëµ¾ÍÏÔµÃÓÈÎªÖØÒª¡£¾¡¹ÜÐÂÒ©Ñз¢µÄÂþÂþ³¤Â·ÉÏÖØÖØÀ§ÄÑ·çÏÕÉõ¸ß£¬µ«ÊÀ½ç¶¥¼âµÄÖÆÒ©ÆóҵÿÄêÒÀȻͶÈë¾Þ´óµÄ×ʽðºÍÈËÁ¦×ÊÔ´ÓÚÐÂÒ©Ñз¢ÁìÓò£¬½«Æä×÷ΪÆóÒµÕ½ÂÔµÄÖØÖÐÖ®ÖØ£¬ÊÓΪ¹ØÏµÆóÒµ´æÍöµÄ¹Ø¼ü¡£ÎÒ¹úÖÆÒ©ÆóÒµÒªÏëÖð²½ËõСÓë·¢´ï¹ú¼ÒÖ®¼äµÄ¾Þ´ó²î¾à£¬ÕæÕýÖ÷µ¼Êг¡£¬±ØÐëÔöÇ¿Ñз¢ÊµÁ¦£¬Ç¿»¯Ñз¢Á÷³Ì¹ÜÀí¼°ÐÅÏ¢»¯¡£È»¶ø£¬ÎÒÃÇÔÚ¹ýÈ¥¼¸Ê®ÄêµÄÐÂÒ©Ñз¢ÖУ¬Ê§°ÜµÄ°¸Àý±È±È½ÔÊÇ, ÆäÖÐ×îÖ÷ÒªµÄÔ­Òò¾ÍÊǶÔÑз¢Á÷³ÌÁ˽ⲻ¹»£¬Ñз¢¹ÜÀí¼°ÐÅÏ¢»¯·½ÃæµÄÂäºóÑÏÖØÖÆÔ¼×ÅÎÒ¹úÆóÒµÐÂÒ©Ñз¢µÄ·¢Õ¹¡£ Òò´Ë£¬ÎªÁËÌá¸ßÒ½Ò©¹¤Òµ½ç¼°¿ÆÑÐѧÊõ½ç¶ÔÐÂÒ©Ñз¢Á÷³Ì¼°ÐÅÏ¢»¯µÄÁ˽⼰ÈÏʶ£¬Ò²ÎªÁ˼ÓÇ¿¸ÃÁìÓòµÄ¹ú¼Ê½»Á÷£¬Ñ°ÕÒºÏ×÷Æõ»ú£¬ÓÉÉϺ£ÉúÎïÐÅÏ¢¼¼ÊõÑо¿ÖÐÐÄ¡¢ÖпÆÔºÉϺ£·ÖÔºÉúÃü¿ÆÑ§Ñо¿Ôº¡¢ÉϺ£½»Í¨´óѧ¡¢º£Õý¼¯ÍÅ£¬ÒÔ¼°InforSenseµÈµ¥Î»½«ÓÚ2008-11-3ºÅÔÚÉϺ£¾Ù°ìÖ÷ÌâΪ¡°ÐÂÒ©Ñз¢Á÷³Ì¼°ÆäÐÅÏ¢»¯¡±µÄ¹ú¼ÊѧÊõ»áÒé¡£»áÒ齫ÑûÇë¹úÄÚ¹¤Òµ¡¢Ñ§Êõ¼°ÆóÒµ½çÖªÃûר¼Ò£¬ÒÔ¼°À´×ÔÅ·ÃÀÒ©Æ·¹ÜÀí»ú¹¹¡¢Ñ§Êõ½ç¡¢ÆóÒµ½çµÄÈËÊ¿¹²Í¬ÑÐÌÖ½»Á÷¡£ÎÒÃÇÖÔÐÄ»¶Ó­¸÷λͬÈʲμӴ˴λáÒ飬¹²Í¬Îª´Ù½øÎÒ¹úÒ©ÎïÑз¢ÊÂÒµµÄ·¢Õ¹¼°¼ÓÇ¿¹ú¼ÊѧÊõ½»Á÷¶øÅ¬Á¦¡£»áÒéÖ®ºó£¬ÎÒÃǽ«ÓëNovartisÖÆÒ©¹«Ë¾ºÏ×÷£¬ÑûÇëPK/PD·ÖÎö¹ú¼ÊÖøÃûµÄר¼Ò£¬Pharsight¹«Ë¾µÄCTO, WinNonlinÈí¼þ¼°¡¶Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications¡·ÊéµÄ×÷ÕßDr. Daniel L. Weiner£¬Ö÷½²µÚ¶þ½ìInforSenseÓëPharsightÒ©´ú¶¯Á¦Ñ§·ÖÎöÁªºÏÅàѵ°à£¬»áÒé¼°Åàѵ°àµÄÏêÇéÇë²Î¼û»áÒéÍøÕ¾£ºwww.drugdiscovery-china.cn

Ö÷°ìµ¥Î»
  InforSense
  Õã½­º£ÕýÒ©Òµ¹É·ÝÓÐÏÞ¹«Ë¾
  ÉϺ£ÉúÎïÐÅÏ¢¼¼ÊõÑо¿ÖÐÐÄ
  ÖпÆÔºÉϺ£ÉúÃü¿ÆÑ§Ñо¿Ôº
  ÉϺ£½»Í¨´óѧ

»áÒéÒéÌâ
1.  ´´ÐÂÒ©µÄÑз¢Á÷³Ì¼°ÐÅÏ¢»¯
2.  ÈçºÎÓÐЧµØÆÀ¹À¼°ÓÅÑ¡Ïȵ¼»¯ºÏÎï
3.  ´´ÐÂÒ©µÄÉè¼ÆË¼Â·
4.  »¯Ñ§Ò©ÎïµÄÉè¼Æ¼°ÈçºÎÓ¦¶Ô֪ʶ²úȨµÄÌôÕ½
5.  Ò©´úÓë¶¾Àí°²È«ÔÚ´´ÐÂÒ©ÖеÄ×÷Óü°µØÎ»

ʱ¼äµØµã
1.  Ê±¼ä£º2008Äê11ÔÂ2ÈÕ12µãÒԺ󱨵½£¬3ÈÕ»áÒ飬4-5ÈÕ»áºóÅàѵ¡£
2.  µØµã£ºÉϺ£»ªÃÀ´ïÐËÔ°±ö¹Ý£¬µØÖ·£ºÉϺ£ÊÐÐì»ãÇøä·509ºÅ

Òé³Ì°²ÅÅ
µÚÒ»²¿·Ö:
´ó»á±¨¸æ ´´ÐÂÒ©µÄÑз¢Á÷³Ì¼°ÐÅÏ¢»¯
µÚ¶þ²¿·Ö:
´´ÐÂÒ©µÄÉè¼ÆË¼Â·,»¯Ñ§Ò©µÄÉè¼Æ
Ò©´ú¶¯Á¦Ñ§Ñо¿
Ò©ÎïÑз¢µÄÐÅÏ¢»¯£¬Ò©ÎïÐÂÖÆ¼ÁµÄÑз¢¼°Ò©ÎïÑз¢Íâ°üµÄÐÅÏ¢»¯
µÚÈý²¿·Ö:
»¯Ñ§Ò©ÎïµÄÉè¼Æ¼°ÈçºÎÓÐЧµØÆÀ¹À¼°ÓÅÑ¡Ïȵ¼»¯ºÏÎï,
Ò©´úÓë¶¾Àí°²È«ÔÚ´´ÐÂÒ©ÖеÄ×÷Óü°µØÎ»
»áºóÅàѵ²¿·Ö:
µÚ¶þ½ìInforSenseÓëPharsightÒ©´ú¶¯Á¦Ñ§·ÖÎöÁªºÏÅàѵ°à£¬ÏêÇé¼ûÏà¹ØÅàѵ

±¨¸æ¼Î±ö
(°´Ãû×ֱʻ­ÅÅÁÐ)
µËÌì¾´   PhD. ±£Åµ¹«Ë¾·ÖÎö»¯Ñ§×ܼà, Pfizer¹«Ë¾Ç°¸ß¼¶·ÖÎö»¯Ñ§¿ÆÑ§¼Ò
Ê·Óñ¹â   ±öϦ·¨ÄáÑÇÖÝÁ¢´óѧÖÕÉí½ÌÊÚ£¬Nature Drug Discovery×ÛÊöÌØÔ¼×«¸åÈË
ÀîÒàѧ   ÉϺ£ÉúÎïÐÅÏ¢¼¼ÊõÑо¿ÖÐÐÄÖ÷ÈΣ¬Öйú¿ÆÑ§ÔºÉϺ£ÉúÃü¿ÆÑ§Ñо¿ÔºÑо¿Ô±£¬¹ú¼Ò¡°Ê®Î塱¸ß¼¼Êõ·¢Õ¹¼Æ»®£¨863¼Æ»®£©ÉúÎïºÍũҵ¼¼ÊõÁìÓòÉúÎïÐÅÏ¢¼¼ÊõÖ÷Ìâר¼Ò×é×鳤¡¢¹ú¼ÒÖг¤ÆÚ¹æ»®¿Æ¼¼Ìõ¼þƽ̨רÌâ×鸱×鳤
Àî¸ï   PhD.,Ò©Ã÷¿µµÂ×ܲüæÊ×ϯִÐйÙ
À   ²©Ê¿,Ñо¿Ô±,ÖйúÒ©Æ·ÉúÎïÖÆÆ·¼ì¶¨Ëù£¬¹ú¼ÒÒ©ÎﰲȫÆÀ¼Û¼à²âÖÐÐÄÖ÷ÈÎ,¹ú¼ÒÒ©µäίԱ»áίԱ£¬
À   Shenogen ***£¬ Cofounder
Îâ´«±ò   ÖÐɽ´óÑ§Ò©Ñ§ÔºÖÆ¼Áϵ Ö÷ÈÎ
ÕżÌÔ¾  PhD. Head of MAP (Metabolism and Pharmacokinetics), China Novartis Institutes for Biomedical Research Co., Ltd.
ºîÔÆµÂ   Ò½¿ÆÔº²¡¶¾Ëù£¨Ò½¿ÆÔºÒ©ÎïËù£¬¹¤³ÌԺԺʿ£©
Ðì¾þ   PhD., ×ܲüæÊ×ϯ¿ÆÑ§¼Ò£¬ÃÀ¹úÉúÎﻯѧÐÍ×éÑо¿Ëù£¬±±¾©Ê±´ú¿¬Ä£¿Æ¼¼ÓÐÏÞ¹«Ë¾
¹ùÒã¿É   Â×¶Ø´óѧµÛ¹úÀí¹¤Ñ§Ôº¼ÆËã»úϵ¼ÆËã»ú¿ÆÑ§½ÌÊÚ£¬ÉϺ£ÉúÎïÐÅÏ¢¼¼ÊõÑо¿ÖÐÐÄ¿Í×ù½ÌÊÚ¡¢Ê×ϯ¿ÆÑ§¼Ò£¬µÛ¹úÀí¹¤Ñ§Ôº²¢ÐмÆËãÖÐÐļ¼Êõ×ܼ࣬Ӣ¹úInforSenseÓÐÏÞ¹«Ë¾Ê×ϯִÐйÙ
³ÏÈÆ½   ÉîÛÚ΢оÉúÎ﹫˾¶­Ê¡¢×ܲüæÊ×ϯ¿ÆÑ§¹Ù
Daniel L. Weiner   PhD. Pharsight CTO, WinNonLinµÄ×÷ÕßÒÔ¼°¡¶Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications¡·µÄ×÷Õß
Stephen Calvert   Ex-VP, Cheminformatics, GSK

»áÒé×¢²á
×¢²á·ÑÓãº
ʱ¼ä   ²Î»á´ú±í   Ñ§Éú
2008.10.15ǰ   ¹¤ÒµÓû§1000Ôª/ÈË,ѧÊõ800Ôª/ÈË   400Ôª/ÈË
2008.10.15ºó/ÏÖ³¡×¢²á   ¹¤ÒµÓû§1200Ôª/ÈË, ѧÊõ1000Ôª/ÈË   500Ôª/ÈË
×¢²á·ÑÓðüÀ¨»áÎñ·Ñ¡¢×ÊÁÏ·Ñ¡£
´Ë´Î»áÒéÕë¶ÔѧÉúÓÐÊý¸öÃâ·ÑÃû¶î¡£ÔÚ10ÔÂ15ºÅ֮ǰÌá½»»ØÖ´µÄѧÉú£¬Èç¹ûûÓÐÉêÇëµ½Ãâ·ÑÃû¶îÕߣ¬ÈÔ°´400Ôª/È˼ÆËã¡£¾­ÉóÆÀ»ñµÃÃâ·ÑÃû¶îµÄѧÉú¿ÉÔÚ10Ôµ׵õ½Í¨Öª¡£

»áºóÅàѵ·ÑÓãº
Êշѱê׼Ϊ6000Ôª/ÈË; ÔÚ2008Äê10ÔÂ15ºÅ֮ǰ£¬½«Åàѵ·ÑÓû㵽¹«Ë¾ÕÊ»§ÄÚ£¬¿ÉÃâ·ÑµÃµ½È«ÏµÁеÄWinNonlinÅàѵ½Ì³Ì¡£ÔÚ´ËÖ®ºó½É·ÑµÄÁíÊÕÅàѵ×ÊÁÏ·Ñ300Ôª/ÈË¡£

×¢²áÁ÷³Ì£º
1.  Ìîд±¨Ãû±í¼ÄÍù/´«ÕæÃØÊé´¦£¨»òÍøÉϱ¨Ãû£©---ÌîÐ´ÃØÊé´¦¼Ä·¢µÄ×¢²á±í---×¢²á±í¼°»ã¿îƾ֤´«Õæ/¼Ä»ØÃØÊé´¦---ÏÖ³¡±¨µ½£¬¿ª¾ß·¢Æ±---ÁìÈ¡»áÒé×ÊÁÏ---½»ÄÉסË޷Ѳ¢Èëס¡£
2.  Ìîд±¨Ãû±í¼ÄÍù/´«ÕæÃØÊé´¦£¨»òÍøÉϱ¨Ãû£©---ÏÖ³¡±¨µ½½ÉÄÉ×¢²á·Ñ£¬¿ª¾ß·¢Æ±---ÁìÈ¡»áÒé×ÊÁÏ---½»ÄÉסË޷Ѳ¢Èëס¡£

½É·Ñ·½Ê½
ÒøÐеç»ã
»§ Ãû£ºÔÏíçÊ«Èí¼þ¼¼Êõ£¨ÉϺ££©ÓÐÏÞ¹«Ë¾
¿ª»§ÐУºÖÐÐÐÉϺ£ÊÐÌïÁÖ·֧ÐÐ
ÕÊ ºÅ£º044227-8500-14606008091001
  ±¨µ½Ê±ÇëЯ´ø±¾ÈËÉí·ÝÖ¤£¬Ñ§Éú´ú±íÐèЯ´øÑ§ÉúÖ¤»òµ¥Î»Ö¤Ã÷¡£Òѽ»·Ñ´ú±íÇë´øºÃ»ã¿îƾ֤£¬ÒÔ±¸ºË¶Ô¡£
  ²Î»á´ú±í½»Í¨·Ñ¡¢²Í·ÑºÍסËÞ·Ñ×ÔÀí¡£²Î»á´ú±í¿É²Î¼Ó»áÒé×éÖ¯ËùÓл¡£»áÒéÌṩ»á³¡ÉϺ£»ªÃÀ´ïÐËÔ°±ö¹ÝµÄÓŻݼ۸ñΪ480Ôª/ÿ±ê×¼¼ä/ÿÌ죬Èç¹ûͬÒâÆ´·¿µÄΪ240Ôª/ÿÈË/ÿÌ죬ͬʱ×éÖ¯·½»¹¿ÉÒÔΪÄú´ú¶©¸½½üµÄ±ö¹Ý£¬¼Û¸ñΪ100ÖÁ2000RMB¼ä²»µÈ£¬ÇëÐèÒªµÄ²Î»áÈËÔ±Óë»áÎñ×éÁªÏµ¡£
  ÍË·Ñ˵Ã÷£ºÒѽ»·ÑµÄ²Î»á´ú±íÒò¸öÈËÔ­Òò²»Äܲλá»òÆäËûÔ­ÒòÐèÒªÍ˿ÇëÌáǰÓë»áÎñ×éÁªÏµ¡£10ÔÂ20ÈÕǰÍË»¹Ëù½»¿îÏîµÄ80%£¬10ÔÂ20ÈÕ¼°ÒÔºóË¡²»Í˿

ÐÒÔ˳齱
ÔÚ2008Äê10ÔÂ31ÈÕǰע²á²¢Íê³É¸¶¿îµÄ²Î»áÈËÔ±£¬¾ùÓлú»á³éȡһ²¿iPod Touch£¡¾¡Ôç×¢²á£¬°ÑÎÕ»ú»á£¡

[ Last edited by Discovery8231 on 2008-10-13 at 14:24 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

·çÖ®»ó

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¿ÆÑб¦¿âÇø

¹ã¸æÏÓÒÉ£¡
°®ÇéҪʼÖÕÈçÒ»£¬¿ÉÊÇÓÄ»áµÄµØµãÒª²»¶Ï±ä»»£¡
2Â¥2008-10-13 14:18:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Discovery8231 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á +13 µ¾ÆÞС±à 2026-03-26 13/650 2026-03-29 08:20 by fmesaito
[¿¼ÑÐ] 0703»¯Ñ§ +11 ÄÝÄÝninicgb 2026-03-27 11/550 2026-03-29 06:45 by 544594351
[¿¼ÑÐ] 322Çóµ÷¼Á +7 ËÎÃ÷ÐÀ 2026-03-27 7/350 2026-03-28 21:27 by sanrepian
[¿¼ÑÐ] Çóµ÷¼Á +7 ÕùÈ¡¾Åµã˯ 2026-03-28 8/400 2026-03-28 21:07 by ÕùÈ¡¾Åµã˯
[¿¼ÑÐ] 322Çóµ÷¼Á +5 ¾É… 2026-03-24 5/250 2026-03-28 13:26 by Iveryant
[¿¼ÑÐ] 286Çóµ÷¼Á +4 ¶ªµôÀÁ¶è 2026-03-27 7/350 2026-03-28 08:07 by baoball
[¿¼ÑÐ] 265Çóµ÷¼Á +8 Сľ³æ085600 2026-03-27 8/400 2026-03-27 22:16 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 0856µ÷¼Á +5 ÇóÇóÈÃÎÒÓÐÊé¶Á° 2026-03-26 6/300 2026-03-27 15:12 by caszguilin
[¿¼ÑÐ] 316Çóµ÷¼Á +5 Pigcasso 2026-03-24 5/250 2026-03-27 12:10 by zhshch
[¿¼ÑÐ] ¿¼Ñе÷¼Á +9 СÀ¯ÐÂ±Ê 2026-03-26 9/450 2026-03-27 11:10 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Çóµ÷¼Á323²ÄÁÏÓ뻯¹¤ +7 1124361 2026-03-24 7/350 2026-03-27 10:22 by wangjy2002
[¿¼ÑÐ] 336²ÄÁÏÇóµ÷¼Á +7 ³ÂäÞÓ¨ 2026-03-26 9/450 2026-03-27 00:20 by wxiongid
[¿¼ÑÐ] Çóµ÷¼Á Ò»Ö¾Ô¸ ±¾¿Æ ±±¿Æ´ó »¯Ñ§ 343 +6 13831862839 2026-03-24 7/350 2026-03-26 22:57 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] »úеѧ˶310·Ö£¬ÊýÒ»Ó¢Ò»£¬Ò»Ö¾Ô¸211±¾¿ÆË«·ÇÕÒµ÷¼ÁÐÅÏ¢ +3 @357 2026-03-25 3/150 2026-03-26 16:34 by by.MENG
[¿¼ÑÐ] ÉúÎï¼¼ÊõÓ빤³Ì +3 1294608413 2026-03-25 4/200 2026-03-25 18:02 by 1294608413
[¿¼ÑÐ] Çóµ÷¼Á +3 ÀîÀî²»·þÊä 2026-03-25 3/150 2026-03-25 13:03 by cmz0325
[¿¼ÑÐ] Ò»Ö¾Ô¸±±»¯315 Çóµ÷¼Á +3 akrrain 2026-03-24 3/150 2026-03-24 19:35 by ÁËÁËÁËÁË¡£¡£
[¿¼ÑÐ] Çóµ÷¼Á +6 ÑÐÑУ¬½Óµç»° 2026-03-24 7/350 2026-03-24 17:01 by barlinike
[¿¼ÑÐ] һ־Ըɽ¶«´óѧҩѧѧ˶Çóµ÷¼Á +3 ¿ª¿ªÐÄÐÄû·³ÄÕ 2026-03-23 4/200 2026-03-24 00:06 by ¿ª¿ªÐÄÐÄû·³ÄÕ
[¿¼ÑÐ] ²ÄÁÏ/ũҵרҵ£¬07/08¿ªÍ·¾ù¿É£¬¹ýÏß¾ÍÐÐ +3 ºÇßíŶ»í 2026-03-23 4/200 2026-03-23 22:30 by Íô£¡£¿£¡
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û